Tag

Regulation

2012 Potpourri XXXVII

By | Commentary | No Comments

Our latest Potpourri captures the excitement of the holidays with scintillating items on certificate of need program effects on utilization, the public’s views on health care costs and government’s role in health care, the cost of developing new drugs and a survey on physician compensation.

Read More

2012 Potpourri XV

By | Commentary | No Comments

Another tremendous edition of our Potpourri, featuring accountable care organization results, waste in our health system, self-referral costs, calculating hospital readmission rates and the benefits, if any, of telemonitoring frail seniors.

Read More

FDA Strategic Plan

By | Commentary | No Comments

The Food & Drug Administration releases its strategic plan for regulatory science, identifying priority areas and implementation strategies for each. How the FDA carries out its strategy over the next few years will greatly affect both the medical products industry and overall health spending.

Read More

FDA’s 510(k) Recommendations

By | Commentary | No Comments

The FDA’s 510(k) medical device approval process has been criticized for requiring too little data on potentially harmful devices. The FDA undertook a review of the process and has issued a description of initial steps it plans to take, which the industry seems to view as acceptable.

Read More